文献
J-GLOBAL ID:201602237714793372
整理番号:16A1370086
転移性大腸癌患者のための第一線のmFOLFOX6+ベバシズマブおよびFOLFIRI+ベバシズマブからなる交互処方の第2相試験-FIREFOX+ベバシズマブ試験(KSCC0801)
Phase II trial of an alternating regimen consisting of first-line mFOLFOX6 plus bevacizumab and FOLFIRI plus bevacizumab for patients with metastatic colorectal cancer: FIREFOX plus bevacizumab trial (KSCC0801)
著者 (16件):
Miwa Keisuke
(Kurume University Hospital)
,
Oki Eiji
(Kyushu University)
,
Emi Yasunori
(Saiseikai Fukuoka General Hospital)
,
Saeki Hiroshi
(Kyushu University)
,
Kusumoto Tetsuya
(National Kyushu Medical Center)
,
Akagi Yoshito
(Kurume University School of Medicine)
,
Ogata Yutaka
(Kurume University Medical Center)
,
Samura Hironori
(Ryukyu University)
,
Tokunaga Shoji
(Kyushu University Hospital)
,
Ishikawa Hiroshi
(Sasebo City General Hospital)
,
Tanaka Takaho
(Social Insurance Tagawa Hospital)
,
Sueyoshi Susumu
(Omuta City Hospital)
,
Higashi Hidefumi
(Steel Memorial Yawata Hospital)
,
Matsuda Hiroyuki
(Hiroshima Red Cross Hospital and Atomic Bomb Survivors Hospital)
,
Touyama Tetsuo
(Nakagami Hospital)
,
Maehara Yoshihiko
(Kyushu University)
資料名:
International Journal of Clinical Oncology
(International Journal of Clinical Oncology)
巻:
21
号:
1
ページ:
110-117
発行年:
2016年02月
JST資料番号:
L3966A
ISSN:
1341-9625
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)